Although timely initiation of insulin for T2DM has been recommended to prevent diabetes related complications by early establishment of strict glycemic control and pancreatic beta-cell protection [17], greater proportion of patients with suboptimal glucose level tend to delay insulin therapy [18] due to fear of hypoglycemia and weight gain [19,20]. The gene discussed is INS; the disease is type 2 diabetes mellitus.